Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1326-1328

  Walker, Kyle M ^a   Pope, Janet ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Scleroderma; Survey; Systemic sclerosis; Treatment guidelines

Indexed keywords

BOSENTAN; ILOPROST; METHOTREXATE; PROSTACYCLIN; PROTON PUMP INHIBITOR;

ARTICLE; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; EUROPE; GASTROESOPHAGEAL REFLUX; HEALTH CARE MANAGEMENT; HUMAN; MEDICAL SOCIETY; NORTH AMERICA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SKIN DISEASE; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

CANADA; EPOPROSTENOL; EUROPE; HEALTH SURVEYS; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; METHOTREXATE; NORTH AMERICA; PRACTICE GUIDELINES AS TOPIC; SCLERODERMA, SYSTEMIC; SKIN DISEASES; SOCIETIES, MEDICAL; SULFONAMIDES; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 79960017183     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101262     Document Type: Article

References (6)

1. Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
2. Cabana MD, Rand CS, Powe NR. Why don't physicians follow clinical practice guidelines?: A framework for improvement. JAMA 1999;282:1458-65. (Pubitemid 29493800)
3. Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, et al. A randomized controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 2004;44:1351-8.
4. van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24-week observational trial. Br J Rheumatol 1996;35:364-72.
5. Korn J, Mayes M, Matucci-Cerinic M, Rainisio M, Rainisio M, Pope J, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985-93. (Pubitemid 39643947)
6. Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2011;70:32-8.